Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 211
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT03359538 RAP-ALS — Rapamycin Treatment for ALS |
Rapamycin | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | Azienda Ospedaliero-Universitaria… | Italy · Centro Clinico Nemo, Fondazione Serena Onlus,… | 2017-09-19 → 2022-02-15 | Ouvrir |
| NCT00324454 Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuro… |
levetiracetam | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | Duke University | United States · Duke University ALS Clinic - 932 Morr… | 2006-05 → 2008-06 | Ouvrir |
| NCT04165824 Safety Study of Oral Edaravone Administered in Subjects With ALS |
MT-1186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | United States, Canada, France, Germany, Italy, Japan … | 2019-11-18 → 2021-10-07 | Ouvrir |
| NCT06543823 SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds |
Suprathel 250 | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | Alaa Emara | Germany · Vinzenz von Paul Kliniken gGmbH Marienhospi… | 2025-04-30 → 2027-04 | Ouvrir |
| NCT07739134 Multimodal Tracking of Therapy Activity and Effort During Rehabilitation |
Multimodal Tracking of Therapy Ac… | Sclérose latérale amyotrophique | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | ETH Zurich | Switzerland · Nextherapy AG, Zurich, Switzerland | 2026-06-01 → 2026-12-30 | Ouvrir |
| NCT06286917 InNIVALS — Initiation of Noninvasive Ventilation in ALS Patients With C… |
InNIVALS — Initiation of Noninvas… | Sclérose latérale amyotrophique | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Tampere University | Finland · Tampere University Hospital, Tampere, Finla… | 2024-03-05 → 2029-12 | Ouvrir |
| NCT07088159 Intermediate-size Patient Population Expanded Access Protocol |
Tazbentetol | Sclérose latérale amyotrophique | À vérifier | AVAILABLE | En attente / non publié | Spinogenix | United States · Atlantic Health, Summit, United State… | Non communiqué | Ouvrir |
| NCT07571174 A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Later… |
LY4256984 | Sclérose latérale amyotrophique | Phase 1 | RECRUITING | En attente / non publié | Eli Lilly and Company | Belgium, Canada, Germany, Netherlands, Spain · Herita… | 2026-05-14 → 2029-06 | Ouvrir |
| NCT06453668 AURORA — A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotr… |
TCD601 | Sclérose latérale amyotrophique | Phase 1 | TERMINATED | En attente / non publié | ITB-Med LLC | Sweden · Skåne University Hospital Malmö, Malmö, Swed… | 2024-04-16 → 2026-07-02 | Ouvrir |
| NCT04577404 Safety Extension Study of Oral Edaravone Administered in Subjects With … |
MT-1186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | United States, Canada, France, Germany, Italy, Japan … | 2020-10-29 → 2023-08-09 | Ouvrir |
| NCT07706270 DIAGONALS — Serum Neurofilaments in the Diagnosis of Amyotrophic Latera… |
DIAGONALS — Serum Neurofilaments … | Sclérose latérale amyotrophique | À vérifier | NOT_YET_RECRUITING | En attente / non publié | University Hospital, Montpellier | Non communiqué | 2026-08-01 → 2028-08-01 | Ouvrir |
| NCT00424463 Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients… |
MCI-186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | Japan · National Hospital Organization Miyagi Nationa… | 2007-01-31 → 2009-05-31 | Ouvrir |
| NCT05568615 Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate th… |
MT-1186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | Japan · Fukushima Medical University Hospital, Fukush… | 2022-10-26 → 2023-06-27 | Ouvrir |
| NCT00330681 Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Later… |
MCI-186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | Non communiqué | 2006-05-31 → 2008-09-30 | Ouvrir |
| NCT01492686 Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis |
MCI-186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | Japan · Osaka, Osaka, Japan | 2011-12-31 → 2014-10-31 | Ouvrir |
| NCT04768972 FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and … |
ION363 | Sclérose latérale amyotrophique | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Ionis Pharmaceuticals, Inc. | United States, Belgium, Brazil, Canada, Germany, Irel… | 2021-06-14 → 2028-03 | Ouvrir |
| NCT05562960 PALATIN — Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoanti… |
plasmapheresis | Sclérose latérale amyotrophique | Non applicable | COMPLETED | En attente / non publié | National Taiwan University Hospit… | Taiwan · National Taiwan University Hospital, Taipei,… | 2023-05-01 → 2025-03-31 | Ouvrir |
| NCT07142291 PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS |
Cromolyn Sodium (34.2 mg BID) | Sclérose latérale amyotrophique | Phase 2 | RECRUITING | En attente / non publié | PhenoNet, Inc. | United States, Czechia, Germany, Poland, Serbia, Spai… | 2025-11-25 → 2027-06 | Ouvrir |
| NCT07726563 Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Again… |
plasmapheresis | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | National Taiwan University Hospit… | Taiwan · National Taiwan University Hospital, Taipei … | 2026-05-19 → 2029-07-31 | Ouvrir |
| NCT07400393 MCSP — Healey ALS MyMatch Common Screening Protocol |
MCSP — Healey ALS MyMatch Common … | Sclérose latérale amyotrophique | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Massachusetts General Hospital | Non communiqué | 2026-08 → 2029-03-16 | Ouvrir |
| NCT06704347 Safety Study of XT-150 in Participants With ALS |
XT-150 | Sclérose latérale amyotrophique | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Xalud Therapeutics, Inc. | United States · Barrow Neurological Institute (St. Jo… | 2027-03 → 2028-06 | Ouvrir |
| NCT06578195 ASSESS ALL ALS Study |
ASSESS ALL ALS Study | Sclérose latérale amyotrophique | À vérifier | RECRUITING | En attente / non publié | St. Joseph's Hospital and Medical… | United States, Puerto Rico · Barrow Neurological Inst… | 2024-07-25 → 2029-07-25 | Ouvrir |
| NCT06284161 PEM-SLA — QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up |
PEM-SLA — QCT in ALS Diagnosis, M… | Sclérose latérale amyotrophique | Non applicable | RECRUITING | En attente / non publié | University Hospital, Clermont-Fer… | France · CHU de Clermont-Ferrand, Clermont-Ferrand, F… | 2022-06-28 → 2030-06 | Ouvrir |
| NCT07047209 ACACIA — Trial of Oral Digoxin in Individuals With Amyotrophic Lateral … |
Digoxin | Sclérose latérale amyotrophique | Phase 2 | COMPLETED | En attente / non publié | Massachusetts General Hospital | United States · MGH, Boston, United States | Northwes… | 2025-05-27 → 2026-05-13 | Ouvrir |
| NCT00415519 Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Later… |
MCI-186 | Sclérose latérale amyotrophique | Phase 3 | COMPLETED | En attente / non publié | Shionogi | Non communiqué | 2006-12-31 → 2008-07-31 | Ouvrir |